INTRODUCTION
In 1998, Pfi zer Pharmaceuticals Pty Ltd released Viagra, the fi rst oral treatment for erectile dysfunction. Its marketing strategy was hugely successful. Viagra obtained the fastest initial sales growth of any pharmaceutical product in history and became the second most recognized brand in the English lexicon.
Eleven years later, the erectile dysfunction market has matured and Pfi zer now faces signifi cant challenges. These include increasing competition from other pharmaceuticals, declining market share,
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Sustaining performance: Learning from buyers ' experience of Viagra poor buyer retention rates, shifting buyer expectations and the imminent expiry of its patent in 2012. Pfi zer is now at a crossroads, where it must refl ect on past experience to reassess future marketing strategy.
This article highlights the critical fi ndings in the literature regarding the evolution of the end-user ' s buying process for erectile dysfunction products, with particular focus on problem recognition, information search and post-purchase behaviour. Although these fi ndings are generalizable to other erectile dysfunction products, we have explored Pfi zer ' s current marketing strategy and promotional materials and made specifi c recommendations as to how Pfi zer can reinvigorate and sustain its marketing success into the future.
Several key themes are identifi ed as providing a platform for future marketing strategies. First, men are reluctant to talk about erectile dysfunction with their partner or their doctor. Second, when they do, few men continue using Viagra in the long term. Third, women and partners play a signifi cant role in infl uencing the buying decision process, yet their perspective is rarely considered in most marketing messages.
With these in mind, it is recommended that Pfi zer seek to better understand the needs and wants of partners and use this information to inform targeted promotion. Furthermore, a more sustainable strategy could include a holistic approach to the product involving, for example, Men ' s Health Clinics that screen for erectile dysfunction. Moreover, psychosocial counselling could be important means of improving satisfaction of both men and their partners, which may ultimately lead to greater buyer retention.
PART 1. LITERATURE REVIEW -BUYER BEHAVIOUR
Marketing allows businesses to communicate with its customers. This underpins commercial success. Although important for businesses to understand ' what ' people buy, long-term marketing success depends on understanding ' why ' people buy. 1 Buyers ' demands are infl uenced by internal personal factors (consumer psychology) and external (cultural and social) factors resulting in a complex stimulus-response pathway. 2 Buyer behaviour can be considered a fi ve-stage process involving recognizing a need, searching for information, evaluating alternative products, deciding to purchase and re-evaluating that purchase. 
Problem recognition
The buying process begins when a buyer recognizes a problem -a difference between their actual and desired state. This is infl uenced by personal, cultural and social factors.
Personal factors
The buying decision depends on the degree to which a product is perceived as satisfying either needs or wants. Although needs are primarily physical, they are increasingly confused with wants in a wealthy and materialistic society. 4 Businesses can infl uence perceptions, attitudes and motivations by marketing wants as needs.
Traditionally, pharmaceutical companies manufactured drugs that treated serious medical conditions or alleviated pain and suffering. Clearly, such products satisfi ed needs. However, pharmaceutical companies are increasingly turning to ' lifestyle drugs ' to maintain profi ts. 5 Lifestyle refers to how people live their lives, engage in activities and express interests. Buyers purchase products to support their desired lifestyle. Not surprisingly, this is a growth market in the pharmaceutical industry.
Businesses must capture buyers ' attention in an environment of intense competition for marketing messages. Pharmaceutical companies can infl uence how doctors and patients perceive value in a medication by creating emotive and negative attitudes towards the illnesses and symptoms that they treat. If buyers believe that medications are essential, they are more likely to attribute positive meaning to seeking help from a medical practitioner and more likely to attribute negative meaning to the illness. By infl uencing perceptions and attitudes in this way, pharmaceutical companies can motivate buyers to achieve their desired outcome.
These principals are important in health care, in which the process of identifying a problem and seeking a solution is complex. Health-care purchases are usually important to the buyer, who often lacks confi dence due to inexperience. As a result, the buyer often engages in an extensive decision-making process and consults with a doctor. Men, in particular, have diffi culty recognizing and solving medical ' problems ' . Men often do not seek help because they may not consider their symptoms problematic. For instance, although men report more erectile diffi culties as they age, they do not express more dissatisfaction with their sex life because their expectations adjust. 6 Only 10.5 per cent of men with sexual problems seek help. 7 Furthermore, when men do perceive a problem, they fi nd it diffi cult to discuss it with others, including with their doctor, for fear of perceived weakness. 8 For sexual problems, in particular, men wait 2 years on average after recognizing a problem before consulting a doctor. Only 39.5 per cent and 26 per cent of men with sexual problems talk to their partner or a medical doctor, respectively. Of those who visited a doctor, partners infl uenced almost half.
In 1943, Abraham Maslow described human needs and drives on fi ve hierarchical levels. Sex, erectile dysfunction and medications can be thought of as part of this hierarchy. Physiological needs are the most basic, as they are literal requirements for human survival. They include air, water, sleep, clothing and sex. Evolutionary biologists would argue that sex and reproduction is one of the most powerful human drives. For men, the erection is key to fulfi lling this drive. Erectile dysfunction therefore creates a very real loss for men.
Having satisfi ed their physiological needs, humans seek safety needs. In general, people seek healthy, orderly and predictable lives. The unpredictability of erectile dysfunction and its embodiment of mortality have spawned the medicalization of sexuality. 9 Moreover, men perceive it as impairing their social need for intimacy with their partner. They may worry that society or their partner will no longer accept them as a man if they cannot achieve or maintain an erection. Ultimately, this affects self-esteem as it leads to the perception that they will be less valued. Clearly, cultural and social factors infl uence these perceptions.
Social factors
Social factors infl uence buyer behaviour through perceived acceptance and approval from reference groups, such as family, friends and doctors. 2 Partners are the most infl uential of all. Over 43 per cent of men seek help for erectile dysfunction as a result of partner pressure. 8 Women are 50 per cent more likely than men to visit a doctor and gather health information, making them critical channels of communication to their partners. 10 Moreover, partners perceive erectile diffi culties differently. While men are more likely to feel devastated and ashamed, partners are more willing to accept less frequent sex and more likely to fi nd other ways of obtaining sexual pleasure. 11, 8 Cultural factors Culture refers to the behaviours, beliefs and values shared by a society. As Maslow 12 described, cultural factors infl uence perceptions and attitudes.
Gender is an individual ' s most fundamental identity. Membership of the male sex is signifi ed by the male anatomy. Erection is a key function of the male anatomy. Men are predominantly seen as unemotional and competitive providers, whereas women are seen as nurturing, intimate and emotional. 13 Masculinity and male dominance is therefore enshrined in erections, penetration and sexual activity.
Such tacit cultural norms and role expectations infl uence men ' s buying behaviour. 2 There is increasing social pressure on older men to maintain busy lives and perfect bodies. 10 Virility is portrayed through the media as the ' perfect ' youthful body. The penis is also a socially defi ned sexual tool that is necessary for reproduction and masculinity. For men with erectile dysfunction, re-capturing or maintaining masculinity and sexual performance becomes important. 9 Men seek superior performance in their job, car, investments and erections. Erectile dysfunction impairs a man ' s penis and his self-image. ' No malfunction of the human apparatus -not even cancer or heart disease -can be more painful to the male ego than sexual impotence ' . 14 Moreover, in an increasingly fast-paced and time-poor society, buyers demand quick and easy solutions. This is known as the McDonaldization phenomenon. Consequently, Western culture has embraced binary dichotomous medical diagnoses that are all or nothing. This applies specifi cally to the non-erect penis 1 and has created an expectation that perpetual youthful sex is a requirement for successful living. 15 Erectile dysfunction is now considered a major public health problem, causing ' endemic ' impairment of quality of life.
Information search
Buyers use various channels to gather information about products that might fulfi l their needs. 2 Initially, potential buyers become aware of marketing messages as they recognize a problem and consider potential products. Pharmaceutical companies raise awareness of medications through commercials, celebrity endorsements, health pamphlets and public relations events.
The pharmaceutical industry is unique in that the dissemination of such information is tightly regulated. Prescription medications can only be advertised directly to buyers in the United States (since 1990) and New Zealand (since 1997), although this is subject to tight regulation. In the United States and New Zealand, direct-to-consumer advertising is a signifi cant driver of buyer purchasing decisions, resulting in increased buyer awareness and physician contact. 16 However, 52 per cent of doctors disapprove of direct advertising, perceiving it as biased, unethical and damaging to the doctor -patient relationship, and many buyers agree. 17 Elsewhere, including in Australia and Europe, direct-to-consumer advertising is prohibited. Pharmaceutical marketing therefore primarily seeks to infl uence the doctor and pharmacist who are gatekeepers in the fi nal purchasing decision. Pharmaceutical marketers build upon public sources of information to enhance brand awareness; including academic symposia, public relations events, and sponsorship of sporting events and conferences. 18 Through media exposure, the general public is a secondary target of these events, which are primarily targeted to doctors. 18 Manufacturers also coordinate education campaigns in which they partner with stakeholder groups or health-care providers (such as Men ' s Health Forums) and distribute leafl ets in doctors ' surgeries, offer advice programmes and websites. commercial, personal and professional sources. With the rise of Internet, all of these sources can be found in one place. Buyers now have easy access to blogs, websites and peer-to-peer sites that promote prescription medicines and other products directly to buyers. Pharmaceutical companies offer interactive online health information. This leads to more sophisticated consumers who are more likely to request a particular brand of medication. 17 The Internet is also anonymous and allows men to more comfortably search for sensitive and potentially embarrassing information. 12.5 per cent of men with erectile dysfunction search for information using the Internet. Only 19 per cent of men discuss sexual issues with their doctor. Clearly, the Internet is moving health care away from the doctor, towards a decentralized system in which buyers are skilled in self-diagnosis. 
Post-purchase behaviour
Having purchased a product, buyers evaluate their satisfaction from the purchase decision. If the product performs below the buyer ' s expectation, cognitive dissonance results and buyers form a negative view of the product. They either stop using it, or return it. Such evaluation commonly occurs when the product is expensive or important, such as for medications. 2 It is important for marketers to retain satisfi ed buyers because they are more likely to purchase the product again. 3 For buyers of pharmaceutical products, non-compliance can cause medical complications and increased health-care costs. 21 For pharmaceutical rms, lost sales driven by brand switching and negative word of mouth are estimated at US $ 15 -20 billion annually. 22 Poor compliance also leads to lower prescription revenue for pharmacy retailers. Post-purchase behaviour is therefore often called the holy grail of pharmaceutical marketing. 23 Cost, safety, side-effects and convenience are the main factors infl uencing ongoing medication use. 7 For example, Viagra ' s side-effects include blue vision, fatigue, low blood pressure, and unnatural and prolonged erections. 7 As will be discussed in Part 2, there are also implications for partners and relationships.
PART 2. THE HARD SELL: THE STORY OF PFIZER AND VIAGRA
Before its launch in March 1998, Pfi zer recognized that the potential market for Viagra was vast. Fifty-two per cent of men aged 40 -70 had erectile dysfunction and it affected 100 million men worldwide. 24 However, a signifi cant challenge for Pfi zer was to get men talking about what had always been a socially embarrassing condition. Clearly, the buyer behaviour literature informed Pfi zer ' s strategy.
Infl uencing perceptions of illness and dysfunction
Pfi zer ' s fi rst strategy was to improve problem recognition and persuade men that there is a difference between their actual and desired state. Previously, men never talked about ' impotence ' because it conveyed hopelessness, weakness, humiliation and permanent disability. 25 By redefi ning impotence as ' erectile dysfunction ' , it is now perceived to be a treatable and inevitable circumstance of sexual maturity. 9 Men now talk about their condition.
The term ' erectile dysfunction ' reduces the ambivalence, embarrassment and complexity surrounding male sexuality to a single pharmacological ' cure ' , 25 and shifts the defi nition of ' normal ' from ' average ' (statistical) to ' ideal ' (aspirational). 9 Although a standardized ' functional ' or ' dysfunctional ' erection does not exist, Pfi zer has re-classifi ed and pathologized ' normal ' sexual changes as sexual ' dysfunctions ' .
Pfi zer also seized upon uncertainties regarding the defi nition of erectile dysfunction. By including a ' mild ' category of erectile dysfunction, Pfi zer was able to expand the market from 10 million men with ' impotence ' to 30 million men with ' occasional erectile dysfunction ' . 27 By making the problem seem common, men may be more likely to perceive a solution as socially and culturally appropriate. Unconcerned men may also be encouraged to seek the solution to a problem they never knew they had. Taking this reasoning further, it seems implicit that men who choose not to take Viagra choose to have erectile dysfunction.
Moreover, the publication and dissemination of these high rates of dysfunction gives the impression that normal sexual decline is now a serious public health ' epidemic ' . This has attracted the interest of doctors and the World Health Organization, neither of which have traditionally focussed on lifestyle conditions. Such collaboration has been a useful addition to Pfi zer ' s promotional strategy.
Pfi zer has also challenged society ' s attitudes towards ageing and, in particular, sexual gratifi cation in older people. The average Viagra user is 55 years of age. 28 Pfi zer promotes an idealized culture of ' ageless ' consumers where sex for life can be expected. 26 This facilitates positive dialogue and attitudes to sexuality and sexual expression in older age. 10 Consequently, older people are more likely to adopt both a negative attitude towards their sexual decline and a positive attitude towards Viagra.
Compared to women, men tend to seek unambiguous and practical solutions to problems. 29 By promoting a purely pharmacological remedy to a complex problem, Pfi zer creates a masculine solution. This renders psychological treatments (communication or therapy) as feminine. Viagra can thus be considered a masked utility for masculinity, which is unrelated to desire, attractiveness or emotion. 9 This absolves the consumer from personal responsibility. Likewise, by defi ning the penis as external to the body, erectile dysfunction can be psychologically disowned. This reduces the negative perceptions and attitudes towards seeking information and treatment.
Product promotion
Key to Pfi zer ' s marketing strategy was to create massive public awareness of both erectile dysfunction and Viagra. Between 1999 and 2001, Pfi zer spent over $ 303 million in direct-to-consumer advertising, which included multiple promotion channels.
Pfi zer used celebrity testimony (Republican Senator Bob Dole) to urge television viewers to consult their doctor in case ' Viagra is right for you ' . These advertisements were aired on sports networks alongside other products that appeal to youthful virility. 30 Pfi zer also created pamphlets for doctors to distribute to patients, they contain personal testimony and answer questions about erectile dysfunction. They include self-tests for erectile dysfunction and provocative titles like ' Start Something Over Again ' , ' Prime Time ' and ' Recover Your Love Life ' with images showing relieved couples, who can now have sex again thanks to Viagra.
Viagra was the only prescription medication with its own magazine. LifeDrive offers lifestyle and relationship advice for existing users, as well as pull-out cards that ' get the conversation started ' about erectile dysfunction for new users.
In 1997, Pfi zer funded the International Index of Erectile Function: a 15-item questionnaire that rates satisfaction with erections. Now adopted by the World Health Organization, it defi nes erectile dysfunction as the quantity of sexual intercourse rather than quality of intimacy and includes ' occasional ' erectile dysfunction. Thus, Pfi zer has sponsored categories of illness that expand its market.
In addition to promotional material targeted towards end-users, Pfi zer also targeted the medical profession as key infl uencers of Viagra use. Part of Pfi zer ' s marketing budget funded medical education. 30 In most countries, doctors must undertake continuing medical education to maintain their registration. Sixty per cent of such education is funded by pharmaceutical companies. This is a powerful tool that allows Pfi zer to deliver key messages to opinion leaders and provides unparalleled opportunities to infl uence prescribing habits, particularly in the medication-intensive erectile dysfunction market. 31 Pfi zer also prints thousands of advertisements in the medical press. For instance, between 1998 and 2002, 70 out of 100 issues of the Journal of the American Medical Association contained advertisements from Pfi zer. 9 Even peer-reviewed articles within these journals are sometimes written by authors sponsored by Pfi zer or who serve on the scientifi c advisory council for Viagra. 32 In Australia, direct-to-consumer marketing is prohibited. Pfi zer successfully circumvents this by exposing the Australian public to products, activities and research results through press releases from public relations events or academic symposia that are primarily targeted to doctors. For instance, thousands of stories have been written about Viagra in the popular press. The Sydney Morning Herald and The Age have variously described Viagra as ' the potency wonder drug ' , ' the drug of choice ' and ' the ultimate erection aid ' . Furthermore, in 2000, the Sydney Morning Herald 33 published an advertisement telling Australians that 39 per cent of men who visit General Practitioners have erectile dysfunction.
It featured an image of an unhappy couple at opposite ends of the bed with accompanying text: ' Erection problems: hard to talk about, easy to treat ' . This was sponsored by ' Impotence Australia ' , which was established with funding from Pfi zer. 34 Ostensibly, this is marketing camoufl aged as a public health message.
Retaining buyers
Despite its success in attracting new users, Viagra achieves surprisingly poor long-term satisfaction. While 58 per cent of men with erectile dysfunction consult with a doctor, only 22 per cent use Viagra more than once and only 15.7 per cent used it at the time of the study. 35 One reason for poor long-term satisfaction may be related to partner dissatisfaction. Partners of men taking Viagra sometimes feel pressured into having unwanted, repeated and prolonged sexual intercourse. 36 Others worry that newfound erections might encourage sexual promiscuity. 10 Fear of disapproval or suspicion from partners leads many men not to tell their partners that they use Viagra. 7 Overall, many buyers and their partners report dissatisfaction owing to limited consideration of the psychodynamic consequences of Viagra use. 11 Research suggests that psychotherapy and sex therapy reduce the number of men with ' persistent erectile dysfunction ' by 87 per cent and 95 per cent, respectively. Compared to men taking Viagra alone, men receiving combination group psychotherapy and Viagra were 54 per cent more likely to report sustained improvement and 71 per cent less likely to discontinue treatment. 37 Therefore, while Viagra is an effective treatment for erectile dysfunction, it is even more effective in the long term when combined with appropriate psychological treatments.
Viagra ' s success seems to rely heavily upon traditional heterosexual assumptions: female servitude towards the ' damaged male ego and the unresponsive penis ' ; 10 ' intimacy ' is defi ned as penile-vaginal intercourse; ' sex ' stands for male orgasm; and men have power over women. Men with erections are better men than those without. The fl accid, non-erect penis is an anomaly, while hardness of the penis and the personality are the essence of masculinity. These ' phallocentric ' overtones disregard the feelings of partners and disengage them from participation in recognizing and solving the problem. 27 Cost is another strong driver of ongoing use. 38 Viagra is expensive because it is neither reimbursed by the Pharmaceutical Benefi ts Scheme in Australia, nor by private health insurers in the United States. Many men limit their usage and expenditure by cutting pills in half, 7 which reduces its effectiveness.
In an attempt to better retain users, Pfi zer recently introduced a customer loyalty programme offering free Viagra prescriptions. Pharmacies enrolled and tracked purchases, allowing Pfi zer to better understand its buyers ' behaviour. Differentiating consumers by age, marital status and insurance coverage enabled Pfi zer to customize its marketing messages. Pfi zer also expanded its use of blogs and websites to directly develop customer relationships. On one blog, Pfi zer says ' this is a place for you to have a conversation with us about health issues ' . 39 Such ' conversations ' also enable Pfi zer to gather patient stories and feedback for use in positioning Viagra. However, it is noteworthy that little has been done to address partner dissatisfaction.
Summary
At length, Pfi zer ' s marketing strategy has been hugely successful. Viagra had the fastest initial sales growth of any pharmaceutical product in history. 40 In the fi rst month of its release, nearly 600 000 prescriptions were fi lled. In the fi rst year, Pfi zer registered $ 1.5 billion in sales revenue. 41 Viagra entered the English lexicon, becoming the second-most recognizable brand name in the United States, behind Coca-Cola. 9 Never before had the addition of a single drug to a pharmaceutical company ' s product line resulted in such a signifi cant increase in a stock ' s value. Viagra quadrupled the market for treatment of erectile dysfunction within just 8 months.
PART 3. CRITICAL ANALYSIS AND RECOMMENDATIONS
Despite Pfi zer ' s marketing success, two caveats are apparent from Part 2. First, despite heavy marketing of a new illness, only half of men talked to their doctors about ' erectile dysfunction ' and most waited at least 2 years beforehand. Second, only a minority of men used Viagra in the long term. These fi ndings could provide the platform for future marketing strategies.
Facilitating problem recognition
Part 1 of this report revealed that men are poor at recognizing, accepting or discussing ' problems ' with their doctor. However, Part 2 revealed that interactive health information websites are important ways of getting men to discuss their health. One suggestion is that Pfi zer ' s websites and blogs include information and advice that promotes attendance at specialized primary health clinics, such as ' Men ' s Health Clinics ' .
Given the relationship between erectile dysfunction and other medical conditions, such clinics might include diabetes clinics, prostate checks and cardiovascular disease clinics. These clinics could also adopt standardized health questionnaires that include opportunistic questions about erectile dysfunction. This could increase the number of people diagnosed with erectile dysfunction.
Critical to this recommendation is the training of health-care staff. Research shows that patients play a passive role and would prefer their doctors to initiate discussion about sexual activity. Strategies may include provision of objective and qualitative tools for practitioners to use as well as training sessions to better identify ' at risk ' patients.
There is a very real opportunity for health-care practitioners to initiate and engage in discussion about sexual activity and erectile dysfunction. Through tapping into existing channels, Pfi zer could potentially increase market share through capturing patients who already visit primary health-care services.
Infl uencing the infl uencers
Part 1 of this report highlighted the crucial infl uence of partners in problem recognition. We found that although men are not good at recognizing, accepting or discussing ' problems ' with their partner, yet when they did, their partners encouraged them to see a doctor. Furthermore, women proactively gather and communicate health information to their partners. Part 2 of this report demonstrated that Pfi zer ' s promotional material depicted chauvinistic and myopic defi nitions of sex and intimacy that focused solely on the needs of men and that alienated women and partners. Some women felt that the focus on erections and penetration devalued the importance of intimacy and romance within a relationship, as well as demoting their role to one of sexual servitude.
Clearly, Pfi zer needs to further consider the sensitivities, desires and perceptions of partners and women in their promotional material. Pfi zer might consider targeting Viagra to partners, but in terms that relate to women, not men. As such, Pfi zer should focus less on masculinity, potency and inadequacy, and more on intimacy within the relationship. For instance, Viagra ' s main competitor in the erectile dysfunction market is Cialis. It lasts longer than Viagra (36 hours or ' all weekend ' ). Its manufacturer (Eli Lily) emphasizes sensuality and being able to ' choose the right moment ' , which engages and empowers partners to participate in the decision if and when to have sex. Cialis ' global market share is now 27 per cent. 42 At length, a more holistic understanding of sexual health should support Pfi zer ' s strategy.
Creating long-term satisfaction
Partners infl uence not only problem recognition, but also post-purchase behaviour. Although Part 1 informed us that satisfi ed buyers usually buy the product again, Part 2 suggested that Viagra provided long-term satisfaction in only a minority of men. Furthermore, partners often felt pressured into having sexual intercourse and were concerned that Viagra usage might encourage sexual promiscuity. This suggests that Pfi zer ' s current marketing strategy fails to adequately consider the complex psychosexual and psychodynamic consequences of men regaining their erections, and that these factors actually impair long-term satisfaction.
Interestingly, the combination of Viagra and psychotherapy improved long-term satisfaction with Viagra. This contradicts Pfi zer ' s strategy of redefi ning an illness to fi t a single biochemical cure. Counselling would allow Pfi zer to not only engage with partners, but also prepare and support couples through the changes to their relationship. Such counselling could also form part of the Men ' s Health Clinic model described above. Pfi zer could better target General Practitioners and Urologists to more fully assess how erectile dysfunction affects the couple and tailor treatments accordingly. Similarly, Psychiatrists might also be ideal targets, as they are doctors with dual skills in prescribing both biological and psychological treatments. Furthermore, many physical treatments in psychiatry contribute to erectile dysfunction. 43 
CONCLUSIONS
Unequivocally, Viagra is one of the most successful drugs in history, in terms of sales and profi ts, thanks largely to Pfi zer ' s clever marketing. Despite this, it seems that men remain reluctant to talk about erectile dysfunction with their doctor. When they do talk, few continue using Viagra in the long term. Given the important role of partners in buyer behaviour, we believe that Pfi zer should seek to better understand the needs and wants of partners and then promote tailored marketing messages to them, which would encourage them to suggest Viagra to their partner, not just in the short term.
Therefore, a complete and biopsychosocial understanding of erectile dysfunction is critical to Viagra ' s ongoing success. As Viagra was launched 11 years ago, buyers ' expectations may have changed and men who use Viagra today may want more than just a pill. It is likely that they want to be informed and intelligent consumers; they want to be valued by the manufacturer; and they want to connect with their partner more than just sexually. Likewise, partners want more than just more frequent sex, they want to feel as though their partner also understands their needs. Moreover, they want to feel that their doctor and Pfi zer also understand their needs, as an individual and a partner.
Furthermore, we believe that these messages could be enhanced through targeted marketing of Viagra to specifi c medical professionals, such as Urologists, Psychiatrists and General Practitioners, whose expertise spans not only physical treatments but also psychological and social treatments. This might involve multi-disciplinary Men ' s Health Clinics to screen for erectile dysfunction or psychosocial counselling to improve satisfaction and retention of customers.
At length, we believe that holistic treatment is one key to sustained success by retaining more buyers through improved satisfaction with the product. Given the increasing infl uence of reference groups, growing competition and a maturing product life cycle, now is an ideal opportunity for Pfi zer to re-design existing marketing strategies to better refl ect a deeper understanding of its diverse buyers.
